Medication Brand Name:

Sutent

 
Active Ingredient:
sunitinib malate
 
DIN(s) in Canada:
02280795, 02280809, 02280817
 
francais
Manufacturer/Distributor:
Pfizer Canada Inc.
 
DrugCoverage Category:
Cancer
 
See Also:


Sutent is available in Canada for the treatment of Metastatic Renal Cell Carcinoma (MRCC) and Gastrointestinal Stromal Tumours (GIST). Sutent is an eligible benefit through most private insurance plans, provincial/ territorial drug benefit programs and federal drug plans. See summary below. More detailed information (including reimbursement criteria, guidelines, claim forms) can be accessed by clicking HERE.

Product Monograph
 
Coverage/Reimbursement by Private Insurance Plans in Canada
Sutent is an eligible benefit through most private insurance plans. Some plans may require special or prior authorization before granting coverage. More detailed information (including reimbursement criteria, guidelines, claim forms) can be accessed by clicking HERE
 
Coverage/Reimbursement by Canadian Provincial/Territorial Programs
Province Coverage Program / Eligibility Criteria
Alberta AB Covered Sutent is covered according to eligibility criteria (for Metastatic Renal Cell Carcinoma (MRCC) and Gastrointestinal Stromal Tumours (GIST)) by Alberta Health and Wellness
British Columbia BC Covered Sutent is covered according to eligibility criteria (for Metastatic Renal Cell Carcinoma (MRCC) and Gastrointestinal Stromal Tumours (GIST)) by the BC Cancer Agency
Manitoba MB Covered Sutent is covered according to eligibility criteria (for Metastatic Renal Cell Carcinoma (MRCC)) under the Manitoba Pharmacare Exception Drug Status Program.
New Brunswick NB Covered Sutent is covered according to eligibility criteria (for Metastatic Renal Cell Carcinoma (MRCC) and Gastrointestinal Stromal Tumours (GIST)) by New Brunswick Prescription Drug Program (NBPDP) under the Special Authorization process
Newfoundland & Labrador NL Covered Sutent is covered according to eligibility criteria (for Metastatic Renal Cell Carcinoma (MRCC) and Gastrointestinal Stromal Tumours (GIST)) by the Newfoundland and Labrador Prescription Drug Program's (NLPDP) Special Authorization provision
Northwest Territories NT Covered Sutent is covered according to eligibility criteria (for Gastrointestinal Stromal Tumours (GIST)) by the Northwest Territories Health Benefits Program through the Exception Drug mechanism
Nova Scotia NS Covered Sutent is covered according to eligibility criteria (for Metastatic Renal Cell Carcinoma (MRCC) and Gastrointestinal Stromal Tumours (GIST)) by Nova Scotia Pharmacare through the Exception Drug Status (EDS) process.
Nunavut NU Covered Sutent is covered according to eligibility criteria (for Gastrointestinal Stromal Tumours (GIST)) by the Non-Insured Health Benefits Program
Ontario ON Covered Sutent is covered according to eligibility criteria (for Metastatic Renal Cell Carcinoma (MRCC) and Gastrointestinal Stromal Tumours (GIST)) by the Ontario Drug Benefit (ODB) Program (including clients of the Trillium Drug Program) through the Individual Clinical Review (Section 8) Mechanism.
Prince Edward Island PE Covered Sutent is covered according to eligibility criteria (for Metastatic Renal Cell Carcinoma (MRCC) and Gastrointestinal Stromal Tumours (GIST)) by the PEI High Drug Cost Program
Quebec QC Covered Sutent is covered according to eligibility criteria (for Metastatic Renal Cell Carcinoma (MRCC) and Gastrointestinal Stromal Tumours (GIST)) by the RAMQ and is on the liste de médicaments d'exception.
Saskatchewan SK Covered Sutent is covered according to eligibility criteria (for Metastatic Renal Cell Carcinoma (MRCC)) by the Saskatchewan Health, Drug Plan and Extended Benefits Branch under the Exception Drug Status Program.
Yukon Territory YT Not Covered Sutent is not currently covered by Yukon Pharmacare
 
Coverage/Reimbursement by Canadian Federal Plans
Plan Coverage Program / Eligibility Criteria
Public Services Health Care Plan Possible Coverage Sutent may be covered by the PSHCP
Non-Insured Health Benefits Program Covered Sutent is covered according to eligibility criteria (for Gastrointestinal Stromal Tumours (GIST)) by the NIHB
Veterans Affairs Canada Not Covered Sutent is not covered by VAC
Canadian Forces Health Services Not Covered Sutent is not covered by CFHS
Interim Federal Health Program Possible Coverage Sutent may be covered by the IFHP
Correctional Services Canada Possible Coverage Sutent may be covered by the CSC
 
Health Canada Drug Product Database Listing